Christine Parkinson

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle et al. · The Lancet Oncology · 2017 · 1.9K citations

Pharmacy, Oncology, Pharmacotherapy +14

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

Muhammed Murtaza, Sarah‐Jane Dawson, Dana W.Y. Tsui et al. · Nature · 2013 · 1.6K citations

Medicine, Molecular Biology, Oncology +17

Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA

Tim Forshew, Muhammed Murtaza, Christine Parkinson et al. · Science Translational Medicine · 2012 · 1.3K citations

Medicine, Molecular Genetics, Oncology +17

Enhanced detection of circulating tumor DNA by fragment size analysis

Florent Moulière, Dineika Chandrananda, Anna Piskorz et al. · Science Translational Medicine · 2018 · 1.1K citations · Full text

Medicine, Molecular Biology, Oncology +13

Mutation of <i>FOXL2</i> in Granulosa-Cell Tumors of the Ovary

Sohrab P. Shah, Martin Köbel, Janine Senz et al. · New England Journal of Medicine · 2009 · 771 citations · Full text

Medicine, Genetics, Oncology +17